|
G |
ABCG2 |
ATP binding cassette subfamily G member 2 (JR blood group) |
decreases expression multiple interactions |
EXP |
4-nonylphenol results in decreased expression of ABCG2 protein fulvestrant affects the reaction [4-nonylphenol results in decreased expression of ABCG2 protein] |
CTD |
PMID:27036933 |
|
NCBI chr 4:88,090,264...88,231,626
Ensembl chr 4:88,090,150...88,231,628
|
|
G |
ADAM10 |
ADAM metallopeptidase domain 10 |
multiple interactions |
ISO |
ADAM10 protein affects the reaction [[ADAM17 protein affects the susceptibility to 4-nonylphenol] which affects the secretion of BTC protein]; ADAM10 protein affects the reaction [ADAM17 protein affects the reaction [4-nonylphenol results in increased secretion of HBEGF protein]]; ADAM10 protein affects the reaction [ADAM17 protein affects the reaction [4-nonylphenol results in increased secretion of TGFA protein]] |
CTD |
PMID:28703301 |
|
NCBI chr15:58,588,809...58,749,707
Ensembl chr15:58,588,809...58,749,791
|
|
G |
ADAM17 |
ADAM metallopeptidase domain 17 |
multiple interactions affects response to substance |
ISO |
[ADAM17 protein affects the susceptibility to 4-nonylphenol] which affects the secretion of BTC protein; ADAM10 protein affects the reaction [[ADAM17 protein affects the susceptibility to 4-nonylphenol] which affects the secretion of BTC protein]; ADAM10 protein affects the reaction [ADAM17 protein affects the reaction [4-nonylphenol results in increased secretion of HBEGF protein]]; ADAM10 protein affects the reaction [ADAM17 protein affects the reaction [4-nonylphenol results in increased secretion of TGFA protein]]; ADAM17 protein affects the reaction [4-nonylphenol results in increased secretion of HBEGF protein]; ADAM17 protein affects the reaction [4-nonylphenol results in increased secretion of TGFA protein] |
CTD |
PMID:28703301 |
|
NCBI chr 2:9,488,486...9,555,830
Ensembl chr 2:9,488,486...9,556,732
|
|
G |
ADIPOQ |
adiponectin, C1Q and collagen domain containing |
increases expression |
ISO |
4-nonylphenol results in increased expression of ADIPOQ protein |
CTD |
PMID:24388992 |
|
NCBI chr 3:186,842,710...186,858,463
Ensembl chr 3:186,842,704...186,858,463
|
|
G |
AFAP1L2 |
actin filament associated protein 1 like 2 |
multiple interactions |
EXP |
[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of AFAP1L2 mRNA |
CTD |
PMID:23626723 |
|
NCBI chr10:114,280,725...114,405,175
Ensembl chr10:114,294,824...114,404,756
|
|
G |
AFP |
alpha fetoprotein |
affects binding |
ISO |
4-nonylphenol binds to AFP protein |
CTD |
PMID:23013281 PMID:25349334 |
|
NCBI chr 4:73,436,221...73,456,174
Ensembl chr 4:73,431,138...73,456,174
|
|
G |
AHR |
aryl hydrocarbon receptor |
affects activity affects binding increases activity |
ISO EXP |
4-nonylphenol affects the activity of AHR protein 4-nonylphenol binds to AHR protein 4-nonylphenol results in increased activity of AHR protein |
CTD |
PMID:18294747 PMID:20436506 PMID:28728110 |
|
NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152
|
|
G |
AKT1 |
AKT serine/threonine kinase 1 |
decreases phosphorylation multiple interactions decreases expression |
ISO |
4-nonylphenol results in decreased phosphorylation of AKT1 protein [bisphenol A co-treated with 4-nonylphenol] results in increased expression of AKT1 mRNA; Acetylcysteine inhibits the reaction [4-nonylphenol results in decreased phosphorylation of AKT1 protein]; bisphenol A inhibits the reaction [4-nonylphenol results in decreased expression of AKT1 mRNA] |
CTD |
PMID:26804764 PMID:30228064 |
|
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,759
|
|
G |
AKT2 |
AKT serine/threonine kinase 2 |
increases expression |
ISO |
4-nonylphenol results in increased expression of AKT2 mRNA |
CTD |
PMID:30228064 |
|
NCBI chr19:40,230,317...40,285,345
Ensembl chr19:40,230,317...40,285,536
|
|
G |
AMH |
anti-Mullerian hormone |
decreases expression |
ISO |
4-nonylphenol analog results in decreased expression of AMH mRNA |
CTD |
PMID:27086933 |
|
NCBI chr19:2,249,323...2,252,073
Ensembl chr19:2,249,309...2,252,073
|
|
G |
APAF1 |
apoptotic peptidase activating factor 1 |
affects expression increases expression |
ISO |
4-nonylphenol affects the expression of APAF1 mRNA 4-nonylphenol results in increased expression of APAF1 protein |
CTD |
PMID:26804764 PMID:27109770 |
|
NCBI chr12:98,645,290...98,735,433
Ensembl chr12:98,645,149...98,735,433
|
|
G |
AR |
androgen receptor |
affects activity multiple interactions decreases expression |
ISO EXP |
4-nonylphenol affects the activity of AR protein 4-nonylphenol inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein] 4-nonylphenol analog results in decreased expression of AR mRNA |
CTD |
PMID:16169144 PMID:18294747 PMID:27086933 |
|
NCBI chr X:67,544,021...67,730,619
Ensembl chr X:67,544,021...67,730,619
|
|
G |
ATG12 |
autophagy related 12 |
increases expression |
ISO |
4-nonylphenol results in increased expression of ATG12 mRNA |
CTD |
PMID:28041982 PMID:30228064 |
|
NCBI chr 5:115,828,200...115,841,565
Ensembl chr 5:115,828,200...115,841,837
|
|
G |
ATG3 |
autophagy related 3 |
increases expression |
ISO |
4-nonylphenol results in increased expression of ATG3 mRNA |
CTD |
PMID:28041982 |
|
NCBI chr 3:112,532,510...112,561,962
Ensembl chr 3:112,532,510...112,562,046
|
|
G |
ATG5 |
autophagy related 5 |
increases expression |
ISO |
4-nonylphenol results in increased expression of ATG5 mRNA |
CTD |
PMID:28041982 PMID:30228064 |
|
NCBI chr 6:106,184,476...106,325,760
Ensembl chr 6:106,045,423...106,325,791
|
|
G |
ATG7 |
autophagy related 7 |
increases expression |
ISO |
4-nonylphenol results in increased expression of ATG7 mRNA |
CTD |
PMID:28041982 |
|
NCBI chr 3:11,272,397...11,576,353
Ensembl chr 3:11,272,309...11,557,665
|
|
G |
B3GNT3 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 |
multiple interactions |
EXP |
[4-tert-octylphenol co-treated with 4-nonylphenol] results in increased expression of B3GNT3 mRNA |
CTD |
PMID:23626723 |
|
NCBI chr19:17,794,791...17,813,576
Ensembl chr19:17,794,828...17,813,576
|
|
G |
B4GALT1 |
beta-1,4-galactosyltransferase 1 |
increases expression |
EXP |
4-nonylphenol results in increased expression of B4GALT1 mRNA |
CTD |
PMID:14605097 |
|
NCBI chr 9:33,104,077...33,185,089
Ensembl chr 9:33,100,493...33,167,336
|
|
G |
BAD |
BCL2 associated agonist of cell death |
increases expression |
ISO |
4-nonylphenol results in increased expression of BAD mRNA; 4-nonylphenol results in increased expression of BAD protein |
CTD |
PMID:26804764 PMID:27087316 |
|
NCBI chr11:64,269,828...64,284,704
Ensembl chr11:64,269,830...64,284,704
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
multiple interactions decreases expression increases expression |
ISO EXP |
3-methyladenine promotes the reaction [4-nonylphenol results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [4-nonylphenol results in increased expression of BAX protein] 4-nonylphenol results in decreased expression of BAX mRNA; 4-nonylphenol results in decreased expression of BAX protein 4-nonylphenol results in increased expression of BAX mRNA; 4-nonylphenol results in increased expression of BAX protein |
CTD |
PMID:15461258 PMID:26804032 PMID:26804764 PMID:27087316 PMID:27109770 PMID:30228064 More...
|
|
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
increases expression decreases expression multiple interactions |
EXP ISO |
4-nonylphenol results in increased expression of BCL2 mRNA 4-nonylphenol results in decreased expression of BCL2 mRNA; 4-nonylphenol results in decreased expression of BCL2 protein [bisphenol A co-treated with 4-nonylphenol] results in decreased expression of BCL2 mRNA |
CTD |
PMID:15461258 PMID:26804764 PMID:27087316 PMID:27109770 PMID:30228064 |
|
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
|
|
G |
BCL2L1 |
BCL2 like 1 |
decreases expression |
ISO |
4-nonylphenol results in decreased expression of BCL2L1 mRNA; 4-nonylphenol results in decreased expression of BCL2L1 protein |
CTD |
PMID:27087316 PMID:27109770 |
|
NCBI chr20:31,664,452...31,723,963
Ensembl chr20:31,664,452...31,723,989
|
|
G |
BCL2L11 |
BCL2 like 11 |
increases expression |
ISO |
4-nonylphenol results in increased expression of BCL2L11 protein |
CTD |
PMID:26804764 |
|
NCBI chr 2:111,120,914...111,168,445
Ensembl chr 2:111,119,378...111,168,444
|
|
G |
BECN1 |
beclin 1 |
multiple interactions increases expression |
ISO |
3-methyladenine inhibits the reaction [4-nonylphenol results in increased expression of BECN1 protein]; Acetylcysteine inhibits the reaction [4-nonylphenol results in increased expression of BECN1 protein]; AICA ribonucleotide promotes the reaction [4-nonylphenol results in increased expression of BECN1 protein]; dorsomorphin inhibits the reaction [4-nonylphenol results in increased expression of BECN1 protein]; PRKAA1 protein promotes the reaction [4-nonylphenol results in increased expression of BECN1 protein] 4-nonylphenol results in increased expression of BECN1 mRNA; 4-nonylphenol results in increased expression of BECN1 protein |
CTD |
PMID:26804764 PMID:28041982 PMID:30228064 |
|
NCBI chr17:42,810,132...42,824,282
Ensembl chr17:42,810,134...42,833,350
|
|
G |
BID |
BH3 interacting domain death agonist |
multiple interactions |
ISO |
4-nonylphenol results in increased cleavage of and results in increased activity of BID protein |
CTD |
PMID:22056370 |
|
NCBI chr22:17,734,138...17,774,665
Ensembl chr22:17,734,138...17,774,770
|
|
G |
BTC |
betacellulin |
multiple interactions |
ISO |
[ADAM17 protein affects the susceptibility to 4-nonylphenol] which affects the secretion of BTC protein; [RHBDF2 protein affects the susceptibility to 4-nonylphenol] which affects the secretion of BTC protein; ADAM10 protein affects the reaction [[ADAM17 protein affects the susceptibility to 4-nonylphenol] which affects the secretion of BTC protein] |
CTD |
PMID:28703301 |
|
NCBI chr 4:74,744,759...74,794,523
Ensembl chr 4:74,744,759...74,794,523
|
|
G |
CASP1 |
caspase 1 |
increases expression decreases expression |
ISO |
4-nonylphenol results in increased expression of CASP1 mRNA 4-nonylphenol results in decreased expression of CASP1 mRNA |
CTD |
PMID:27087316 PMID:27109770 |
|
NCBI chr11:105,025,443...105,036,686
Ensembl chr11:105,025,397...105,035,250
|
|
G |
CASP2 |
caspase 2 |
increases expression |
ISO |
4-nonylphenol results in increased expression of CASP2 mRNA |
CTD |
PMID:27087316 |
|
NCBI chr 7:143,288,351...143,307,696
Ensembl chr 7:143,288,215...143,307,696
|
|
G |
CASP3 |
caspase 3 |
increases cleavage multiple interactions affects expression increases expression |
ISO |
4-nonylphenol results in increased cleavage of CASP3 protein 3-methyladenine promotes the reaction [4-nonylphenol results in increased cleavage of CASP3 protein]; 4-nonylphenol results in decreased expression of and results in increased phosphorylation of CASP3 protein; [bisphenol A co-treated with 4-nonylphenol] results in increased expression of CASP3 mRNA; Acetylcysteine inhibits the reaction [4-nonylphenol results in increased cleavage of CASP3 protein]; bisphenol A inhibits the reaction [4-nonylphenol results in increased expression of CASP3 protein modified form] 4-nonylphenol affects the expression of CASP3 mRNA 4-nonylphenol results in increased expression of and results in increased activity of CASP3 protein; [Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of and results in increased activity of CASP3 protein |
CTD |
PMID:22056370 PMID:26804764 PMID:27109770 PMID:29029336 PMID:30228064 |
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
CASP4 |
caspase 4 |
increases expression |
ISO |
4-nonylphenol results in increased expression of CASP4 mRNA |
CTD |
PMID:27087316 |
|
NCBI chr11:104,942,866...104,968,574
Ensembl chr11:104,942,866...104,969,366
|
|
G |
CASP6 |
caspase 6 |
decreases expression |
ISO |
4-nonylphenol results in decreased expression of CASP6 mRNA |
CTD |
PMID:27109770 |
|
NCBI chr 4:109,664,388...109,709,767
Ensembl chr 4:109,688,622...109,703,583
|
|
G |
CASP7 |
caspase 7 |
decreases expression |
ISO |
4-nonylphenol results in decreased expression of CASP7 mRNA |
CTD |
PMID:27109770 |
|
NCBI chr10:113,679,194...113,730,909
Ensembl chr10:113,679,162...113,730,907
|
|
G |
CASP8 |
caspase 8 |
increases cleavage decreases expression increases expression multiple interactions |
ISO |
4-nonylphenol results in increased cleavage of CASP8 protein 4-nonylphenol results in decreased expression of CASP8 mRNA 4-nonylphenol results in increased expression of CASP8 mRNA 4-nonylphenol affects the reaction [bisphenol A results in increased expression of CASP8 mRNA]; bisphenol A affects the reaction [4-nonylphenol results in increased expression of CASP8 mRNA] |
CTD |
PMID:22056370 PMID:27087316 PMID:30228064 |
|
NCBI chr 2:201,233,463...201,287,711
Ensembl chr 2:201,233,443...201,361,836
|
|
G |
CASP9 |
caspase 9 |
increases cleavage increases expression decreases expression |
ISO |
4-nonylphenol results in increased cleavage of CASP9 protein 4-nonylphenol results in increased expression of CASP9 mRNA 4-nonylphenol results in decreased expression of CASP9 mRNA |
CTD |
PMID:22056370 PMID:27087316 PMID:27109770 |
|
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
|
|
G |
CAT |
catalase |
decreases expression |
ISO |
4-nonylphenol results in decreased expression of CAT mRNA |
CTD |
PMID:27087316 PMID:27109770 |
|
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
|
|
G |
CCBE1 |
collagen and calcium binding EGF domains 1 |
multiple interactions |
EXP |
[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of CCBE1 mRNA |
CTD |
PMID:23626723 |
|
NCBI chr18:59,430,939...59,697,721
Ensembl chr18:59,430,939...59,697,662
|
|
G |
CCN5 |
cellular communication network factor 5 |
increases expression multiple interactions |
EXP |
4-nonylphenol results in increased expression of CCN5 mRNA ESR1 protein inhibits the reaction [4-nonylphenol results in increased expression of CCN5 mRNA] |
CTD |
PMID:23384675 |
|
NCBI chr20:44,714,861...44,727,811
Ensembl chr20:44,714,844...44,728,509
|
|
G |
CCNA2 |
cyclin A2 |
decreases expression |
ISO |
4-nonylphenol results in decreased expression of CCNA2 protein |
CTD |
PMID:26804764 |
|
NCBI chr 4:121,816,444...121,823,883
Ensembl chr 4:121,816,444...121,823,883
|
|
G |
CCNB1 |
cyclin B1 |
increases expression |
ISO |
4-nonylphenol results in increased expression of CCNB1 protein |
CTD |
PMID:26804764 |
|
NCBI chr 5:69,167,150...69,178,245
Ensembl chr 5:69,167,135...69,178,245
|
|
G |
CCND1 |
cyclin D1 |
decreases expression increases expression |
ISO EXP |
4-nonylphenol results in decreased expression of CCND1 protein 4-nonylphenol results in increased expression of CCND1 mRNA; 4-nonylphenol results in increased expression of CCND1 protein |
CTD |
PMID:26804032 PMID:26804764 |
|
NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474
|
|
G |
CCNE1 |
cyclin E1 |
decreases expression |
EXP |
4-nonylphenol results in decreased expression of CCNE1 mRNA |
CTD |
PMID:26804032 |
|
NCBI chr19:29,811,991...29,824,312
Ensembl chr19:29,811,991...29,824,312
|
|
G |
CDKN1A |
cyclin dependent kinase inhibitor 1A |
increases expression decreases expression |
ISO EXP |
4-nonylphenol results in increased expression of CDKN1A protein 4-nonylphenol results in decreased expression of CDKN1A protein |
CTD |
PMID:26804032 PMID:26804764 |
|
NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,397
|
|
G |
CDKN1B |
cyclin dependent kinase inhibitor 1B |
increases expression decreases expression |
ISO EXP |
4-nonylphenol results in increased expression of CDKN1B protein 4-nonylphenol results in decreased expression of CDKN1B mRNA |
CTD |
PMID:26804032 PMID:26804764 |
|
NCBI chr12:12,717,368...12,722,369
Ensembl chr12:12,685,498...12,722,369
|
|
G |
CDKN1C |
cyclin dependent kinase inhibitor 1C |
increases expression |
EXP |
4-nonylphenol results in increased expression of CDKN1C protein |
CTD |
PMID:26027920 |
|
NCBI chr11:2,883,218...2,885,775
Ensembl chr11:2,883,213...2,885,775
|
|
G |
CHEK1 |
checkpoint kinase 1 |
increases phosphorylation |
EXP |
4-nonylphenol results in increased phosphorylation of CHEK1 protein |
CTD |
PMID:32466334 |
|
NCBI chr11:125,625,136...125,681,124
Ensembl chr11:125,625,163...125,676,255
|
|
G |
CHEK2 |
checkpoint kinase 2 |
increases phosphorylation |
EXP |
4-nonylphenol results in increased phosphorylation of CHEK2 protein |
CTD |
PMID:32466334 |
|
NCBI chr22:28,687,743...28,741,834
Ensembl chr22:28,687,743...28,742,422
|
|
G |
CHRNA3 |
cholinergic receptor nicotinic alpha 3 subunit |
multiple interactions |
EXP |
4-nonylphenol inhibits the reaction [Acetylcholine affects the activity of [CHRNA3 protein binds to CHRNB4 protein]]; 4-nonylphenol promotes the reaction [Tamoxifen inhibits the reaction [Acetylcholine affects the activity of [CHRNA3 protein binds to CHRNB4 protein]]] |
CTD |
PMID:11711029 |
|
NCBI chr15:78,593,052...78,620,996
Ensembl chr15:78,593,052...78,621,295
|
|
G |
CHRNA4 |
cholinergic receptor nicotinic alpha 4 subunit |
multiple interactions |
EXP |
4-nonylphenol inhibits the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]] |
CTD |
PMID:11711029 |
|
NCBI chr20:63,343,223...63,361,349
Ensembl chr20:63,343,223...63,378,401
|
|
G |
CHRNB2 |
cholinergic receptor nicotinic beta 2 subunit |
multiple interactions |
EXP |
4-nonylphenol inhibits the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]] |
CTD |
PMID:11711029 |
|
NCBI chr 1:154,567,778...154,580,013
Ensembl chr 1:154,567,778...154,580,013
|
|
G |
CHRNB4 |
cholinergic receptor nicotinic beta 4 subunit |
multiple interactions |
EXP |
4-nonylphenol inhibits the reaction [Acetylcholine affects the activity of [CHRNA3 protein binds to CHRNB4 protein]]; 4-nonylphenol promotes the reaction [Tamoxifen inhibits the reaction [Acetylcholine affects the activity of [CHRNA3 protein binds to CHRNB4 protein]]] |
CTD |
PMID:11711029 |
|
NCBI chr15:78,624,111...78,661,641
Ensembl chr15:78,624,111...78,727,754
|
|
G |
COL14A1 |
collagen type XIV alpha 1 chain |
multiple interactions |
EXP |
[4-tert-octylphenol co-treated with 4-nonylphenol] results in increased expression of COL14A1 mRNA |
CTD |
PMID:23626723 |
|
NCBI chr 8:120,124,454...120,373,573
Ensembl chr 8:120,059,780...120,373,573
|
|
G |
CREB1 |
cAMP responsive element binding protein 1 |
multiple interactions |
EXP |
[4-tert-octylphenol co-treated with 4-nonylphenol] results in increased phosphorylation of CREB1 protein; wortmannin inhibits the reaction [[4-tert-octylphenol co-treated with 4-nonylphenol] results in increased phosphorylation of CREB1 protein] |
CTD |
PMID:23626723 |
|
NCBI chr 2:207,529,962...207,605,988
Ensembl chr 2:207,529,737...207,605,988
|
|
G |
CSF1R |
colony stimulating factor 1 receptor |
multiple interactions |
EXP |
[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of CSF1R mRNA |
CTD |
PMID:23626723 |
|
NCBI chr 5:150,053,295...150,113,365
Ensembl chr 5:150,053,291...150,113,372
|
|
G |
CSF2 |
colony stimulating factor 2 |
increases secretion |
EXP |
4-nonylphenol results in increased secretion of CSF2 protein |
CTD |
PMID:20194071 |
|
NCBI chr 5:132,073,789...132,076,170
Ensembl chr 5:132,073,789...132,076,170
|
|
G |
CTSD |
cathepsin D |
increases expression |
EXP |
4-nonylphenol results in increased expression of CTSD protein |
CTD |
PMID:26804032 |
|
NCBI chr11:1,752,755...1,763,927
Ensembl chr11:1,752,752...1,764,573
|
|
G |
CYP11A1 |
cytochrome P450 family 11 subfamily A member 1 |
multiple interactions |
ISO |
[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in decreased expression of CYP11A1 mRNA |
CTD |
PMID:29029336 |
|
NCBI chr15:74,337,762...74,367,646
Ensembl chr15:74,337,759...74,367,646
|
|
G |
CYP17A1 |
cytochrome P450 family 17 subfamily A member 1 |
multiple interactions decreases expression |
ISO |
[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of CYP17A1 mRNA 4-nonylphenol results in decreased expression of CYP17A1 mRNA |
CTD |
PMID:29029336 |
|
NCBI chr10:102,830,531...102,837,413
Ensembl chr10:102,830,531...102,837,472
|
|
G |
CYP19A1 |
cytochrome P450 family 19 subfamily A member 1 |
decreases expression multiple interactions |
ISO |
4-nonylphenol results in decreased expression of CYP19A1 mRNA; 4-nonylphenol results in decreased expression of CYP19A1 protein [Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in decreased expression of CYP19A1 mRNA; [Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in decreased expression of CYP19A1 protein |
CTD |
PMID:29029336 |
|
NCBI chr15:51,208,057...51,338,596
Ensembl chr15:51,208,057...51,338,601
|
|
G |
CYP1B1 |
cytochrome P450 family 1 subfamily B member 1 |
decreases expression |
ISO |
4-nonylphenol results in decreased expression of CYP1B1 mRNA |
CTD |
PMID:27087316 PMID:27109770 |
|
NCBI chr 2:38,067,509...38,076,151
Ensembl chr 2:38,066,973...38,109,902
|
|
G |
CYP2B6 |
cytochrome P450 family 2 subfamily B member 6 |
increases expression multiple interactions |
EXP ISO |
4-nonylphenol results in increased expression of CYP2B6 mRNA 4-nonylphenol promotes the reaction [NR1I3 protein results in increased expression of CYP2B10 mRNA] 4-nonylphenol results in increased expression of CYP2B10 mRNA 4-nonylphenol promotes the reaction [NR1I3 protein results in increased expression of CYP2B6 mRNA]; [4-nonylphenol inhibits the reaction [androstan-3-ol binds to and results in decreased activity of NR1I3 protein]] which results in increased expression of CYP2B6 mRNA; NR1I3 protein promotes the reaction [4-nonylphenol results in increased expression of CYP2B10 mRNA] |
CTD |
PMID:17483497 |
|
NCBI chr19:40,991,282...41,018,398
Ensembl chr19:40,991,282...41,018,398
|
|
G |
DIO2 |
iodothyronine deiodinase 2 |
multiple interactions |
EXP |
[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of DIO2 mRNA |
CTD |
PMID:23626723 |
|
NCBI chr14:80,197,526...80,231,057
Ensembl chr14:80,197,526...80,387,757
|
|
G |
DNMT3A |
DNA methyltransferase 3 alpha |
multiple interactions |
EXP |
[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of DNMT3A mRNA; [4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of DNMT3A protein; wortmannin inhibits the reaction [[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of DNMT3A protein] |
CTD |
PMID:23626723 |
|
NCBI chr 2:25,227,874...25,342,590
Ensembl chr 2:25,227,855...25,342,590
|
|
G |
DNMT3B |
DNA methyltransferase 3 beta |
multiple interactions |
EXP |
[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of DNMT3B mRNA; [4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of DNMT3B protein; wortmannin inhibits the reaction [[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of DNMT3B protein] |
CTD |
PMID:23626723 |
|
NCBI chr20:32,762,385...32,809,356
Ensembl chr20:32,762,385...32,809,359
|
|
G |
DNMT3L |
DNA methyltransferase 3 like |
multiple interactions |
EXP |
[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of DNMT3L mRNA; [4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of DNMT3L protein; wortmannin inhibits the reaction [[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of DNMT3L protein] |
CTD |
PMID:23626723 |
|
NCBI chr21:44,246,339...44,261,897
Ensembl chr21:44,246,339...44,262,216
|
|
G |
EBF2 |
EBF transcription factor 2 |
multiple interactions |
EXP |
[4-tert-octylphenol co-treated with 4-nonylphenol] results in increased expression of EBF2 mRNA |
CTD |
PMID:23626723 |
|
NCBI chr 8:25,841,725...26,045,413
Ensembl chr 8:25,841,725...26,045,413
|
|
G |
EEIG1 |
estrogen-induced osteoclastogenesis regulator 1 |
increases expression |
EXP |
4-nonylphenol results in increased expression of EEIG1 mRNA |
CTD |
PMID:14605097 |
|
NCBI chr 9:127,940,582...127,980,989
Ensembl chr 9:127,940,582...127,980,989
|
|
G |
EIF4EBP1 |
eukaryotic translation initiation factor 4E binding protein 1 |
decreases phosphorylation multiple interactions |
ISO |
4-nonylphenol results in decreased phosphorylation of EIF4EBP1 protein Acetylcysteine inhibits the reaction [4-nonylphenol results in decreased phosphorylation of EIF4EBP1 protein]; dorsomorphin inhibits the reaction [4-nonylphenol results in decreased phosphorylation of EIF4EBP1 protein]; PRKAA1 protein promotes the reaction [4-nonylphenol results in decreased phosphorylation of EIF4EBP1 protein] |
CTD |
PMID:26804764 PMID:28041982 PMID:30228064 |
|
NCBI chr 8:38,030,534...38,060,365
Ensembl chr 8:38,030,534...38,060,365
|
|
G |
ERBB2 |
erb-b2 receptor tyrosine kinase 2 |
decreases expression |
EXP |
4-nonylphenol results in decreased expression of ERBB2 mRNA |
CTD |
PMID:16393665 |
|
NCBI chr17:39,688,094...39,728,658
Ensembl chr17:39,687,914...39,730,426
|
|
G |
ESR1 |
estrogen receptor 1 |
multiple interactions decreases expression increases activity affects localization affects binding |
EXP ISO |
4-nonylphenol binds to and results in increased activity of ESR1 protein; 4-nonylphenol inhibits the reaction [Estradiol binds to ESR1 protein]; [4-nonylphenol co-treated with ESR1 protein] results in increased expression of LTF mRNA; ESR1 protein inhibits the reaction [4-nonylphenol results in increased expression of CCN5 mRNA] 4-nonylphenol results in decreased expression of ESR1 mRNA 4-nonylphenol results in increased activity of ESR1 protein; 4-nonylphenol results in increased activity of ESR1 protein mutant form 4-nonylphenol affects the localization of ESR1 protein 4-nonylphenol inhibits the reaction [Estradiol results in increased expression of ESR1 mRNA] 4-nonylphenol binds to ESR1 protein 4-nonylphenol results in decreased expression of ESR1 mRNA; 4-nonylphenol results in decreased expression of ESR1 protein 4-nonylphenol analog results in decreased expression of ESR1 mRNA; 4-nonylphenol analog results in decreased expression of ESR1 protein |
CTD |
PMID:11518614 PMID:11530281 PMID:12127041 PMID:12598185 PMID:16393665 PMID:17141713 PMID:17174995 PMID:19720131 PMID:19913605 PMID:20353888 PMID:20950447 PMID:21783566 PMID:22056370 PMID:23384675 PMID:24388992 PMID:25012808 PMID:27086933 PMID:27633901 PMID:28728110 PMID:29066353 PMID:29162470 More...
|
|
NCBI chr 6:151,656,672...152,129,619
Ensembl chr 6:151,656,691...152,129,619
|
|
G |
ESR2 |
estrogen receptor 2 |
affects localization multiple interactions affects binding decreases expression |
ISO EXP |
4-nonylphenol affects the localization of ESR2 protein 4-nonylphenol inhibits the reaction [Estradiol results in increased expression of ESR2 mRNA] 4-nonylphenol binds to and results in increased activity of ESR2 protein; [4-nonylphenol co-treated with ESR2 protein] results in increased expression of LTF mRNA 4-nonylphenol binds to ESR2 protein 4-nonylphenol analog results in decreased expression of ESR2 mRNA; 4-nonylphenol analog results in decreased expression of ESR2 protein |
CTD |
PMID:11518614 PMID:12224631 PMID:19913605 PMID:20950447 PMID:21783566 PMID:22056370 PMID:27086933 PMID:27633901 More...
|
|
NCBI chr14:64,226,707...64,338,613
Ensembl chr14:64,084,232...64,338,112
|
|
G |
FAM153A |
family with sequence similarity 153 member A |
multiple interactions |
EXP |
[4-tert-octylphenol co-treated with 4-nonylphenol] results in increased expression of FAM153A mRNA |
CTD |
PMID:23626723 |
|
NCBI chr 5:177,694,247...177,783,425
Ensembl chr 5:177,707,981...177,784,435
|
|
G |
FAS |
Fas cell surface death receptor |
increases expression |
ISO |
4-nonylphenol results in increased expression of FAS mRNA; 4-nonylphenol results in increased expression of FAS protein |
CTD |
PMID:27087316 PMID:27109770 |
|
NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
|
|
G |
FASLG |
Fas ligand |
increases expression |
ISO |
4-nonylphenol results in increased expression of FASLG mRNA; 4-nonylphenol results in increased expression of FASLG protein |
CTD |
PMID:27087316 PMID:27109770 |
|
NCBI chr 1:172,659,103...172,666,876
Ensembl chr 1:172,659,103...172,666,876
|
|
G |
FASN |
fatty acid synthase |
increases expression |
ISO |
4-nonylphenol results in increased expression of FASN mRNA |
CTD |
PMID:24388992 |
|
NCBI chr17:82,078,338...82,098,236
Ensembl chr17:82,078,338...82,098,294
|
|
G |
FCGR3A |
Fc gamma receptor IIIa |
multiple interactions |
EXP |
[4-tert-octylphenol co-treated with 4-nonylphenol] results in increased expression of FCGR3A mRNA |
CTD |
PMID:23626723 |
|
NCBI chr 1:161,541,759...161,550,737
Ensembl chr 1:161,541,759...161,550,968
|
|
G |
FOS |
Fos proto-oncogene, AP-1 transcription factor subunit |
increases expression |
EXP |
4-nonylphenol results in increased expression of FOS mRNA; 4-nonylphenol results in increased expression of FOS protein |
CTD |
PMID:24308608 |
|
NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,283,190
|
|
G |
FSHB |
follicle stimulating hormone subunit beta |
decreases expression multiple interactions |
ISO |
4-nonylphenol results in decreased expression of FSHB protein [4-nonylphenol results in increased susceptibility to bisphenol A] which results in increased secretion of FSHB protein |
CTD |
PMID:27087316 PMID:27109770 PMID:30228064 |
|
NCBI chr11:30,231,014...30,235,194
Ensembl chr11:30,231,014...30,235,261
|
|
G |
GCNT4 |
glucosaminyl (N-acetyl) transferase 4 |
multiple interactions |
EXP |
[4-tert-octylphenol co-treated with 4-nonylphenol] results in increased expression of GCNT4 mRNA |
CTD |
PMID:23626723 |
|
NCBI chr 5:75,016,969...75,054,060
Ensembl chr 5:75,025,346...75,052,558
|
|
G |
GH1 |
growth hormone 1 |
increases secretion increases expression multiple interactions |
ISO |
4-nonylphenol results in increased secretion of GH1 protein 4-nonylphenol results in increased expression of GH1 mRNA; 4-nonylphenol results in increased expression of GH1 protein fulvestrant inhibits the reaction [4-nonylphenol results in increased expression of GH1 mRNA]; fulvestrant inhibits the reaction [4-nonylphenol results in increased expression of GH1 protein]; fulvestrant inhibits the reaction [4-nonylphenol results in increased secretion of GH1 protein] |
CTD |
PMID:19145065 PMID:19463694 |
|
NCBI chr17:63,917,203...63,918,839
Ensembl chr17:63,917,200...63,918,839
|
|
G |
GPER1 |
G protein-coupled estrogen receptor 1 |
increases expression |
EXP |
4-nonylphenol results in increased expression of GPER1 mRNA |
CTD |
PMID:29783106 |
|
NCBI chr 7:1,087,118...1,093,810
Ensembl chr 7:1,082,208...1,093,815
|
|
G |
GPX1 |
glutathione peroxidase 1 |
decreases expression |
ISO |
4-nonylphenol results in decreased expression of GPX1 mRNA |
CTD |
PMID:27109770 |
|
NCBI chr 3:49,357,176...49,358,353
Ensembl chr 3:49,357,174...49,358,605
|
|
G |
H2AX |
H2A.X variant histone |
increases phosphorylation |
EXP |
4-nonylphenol results in increased phosphorylation of H2AX protein |
CTD |
PMID:32466334 |
|
NCBI chr11:119,093,874...119,095,465
Ensembl chr11:119,093,874...119,095,465
|
|
G |
HAS2 |
hyaluronan synthase 2 |
multiple interactions |
EXP |
[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of HAS2 mRNA |
CTD |
PMID:23626723 |
|
NCBI chr 8:121,612,116...121,641,440
Ensembl chr 8:121,612,116...121,641,440
|
|
G |
HBEGF |
heparin binding EGF like growth factor |
increases secretion multiple interactions |
ISO |
4-nonylphenol results in increased secretion of HBEGF protein 3-(formylhydroxyamino)-2-(3-phenyl-1-propyl)butanoic acid (2,2-dimethyl-1-methylcarbamoyl-1-propyl)amide inhibits the reaction [4-nonylphenol results in increased secretion of HBEGF protein]; ADAM10 protein affects the reaction [ADAM17 protein affects the reaction [4-nonylphenol results in increased secretion of HBEGF protein]]; ADAM17 protein affects the reaction [4-nonylphenol results in increased secretion of HBEGF protein]; GW280264X inhibits the reaction [4-nonylphenol results in increased secretion of HBEGF protein] |
CTD |
PMID:28703301 |
|
NCBI chr 5:140,332,843...140,346,603
Ensembl chr 5:140,332,843...140,346,603
|
|
G |
HOXA1 |
homeobox A1 |
multiple interactions |
ISO |
4-nonylphenol inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA] |
CTD |
PMID:23696197 |
|
NCBI chr 7:27,092,993...27,096,000
Ensembl chr 7:27,092,993...27,096,000
|
|
G |
HSD11B1 |
hydroxysteroid 11-beta dehydrogenase 1 |
decreases activity |
EXP |
4-nonylphenol results in decreased activity of HSD11B1 protein |
CTD |
PMID:16184081 |
|
NCBI chr 1:209,686,179...209,734,929
Ensembl chr 1:209,686,178...209,734,949
|
|
G |
HSD11B2 |
hydroxysteroid 11-beta dehydrogenase 2 |
decreases activity |
EXP |
4-nonylphenol results in decreased activity of HSD11B2 protein |
CTD |
PMID:16184081 |
|
NCBI chr16:67,429,801...67,437,553
Ensembl chr16:67,430,652...67,437,553
|
|
G |
HSD3B1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
decreases expression |
ISO |
4-nonylphenol results in decreased expression of HSD3B1 mRNA |
CTD |
PMID:29029336 |
|
NCBI chr 1:119,507,203...119,515,058
Ensembl chr 1:119,507,198...119,515,054
|
|
G |
IFNG |
interferon gamma |
affects secretion decreases expression |
EXP ISO |
4-nonylphenol affects the secretion of IFNG protein 4-nonylphenol results in decreased expression of IFNG mRNA |
CTD |
PMID:20194071 PMID:27109770 |
|
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
|
|
G |
IL10 |
interleukin 10 |
increases secretion |
EXP |
4-nonylphenol results in increased secretion of IL10 protein |
CTD |
PMID:20194071 |
|
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
|
|
G |
IL1B |
interleukin 1 beta |
affects secretion affects expression |
EXP ISO |
4-nonylphenol affects the secretion of IL1B protein 4-nonylphenol affects the expression of IL1B mRNA |
CTD |
PMID:20194071 PMID:27109770 |
|
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
IL4 |
interleukin 4 |
affects secretion |
EXP |
4-nonylphenol affects the secretion of IL4 protein |
CTD |
PMID:20194071 |
|
NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
|
|
G |
IYD |
iodotyrosine deiodinase |
multiple interactions |
EXP |
4-nonylphenol inhibits the reaction [IYD protein results in increased metabolism of Monoiodotyrosine] |
CTD |
PMID:33352258 |
|
NCBI chr 6:150,369,012...150,405,969
Ensembl chr 6:150,368,892...150,405,969
|
|
G |
KCNB2 |
potassium voltage-gated channel subfamily B member 2 |
multiple interactions |
EXP |
[4-tert-octylphenol co-treated with 4-nonylphenol] results in increased expression of KCNB2 mRNA |
CTD |
PMID:23626723 |
|
NCBI chr 8:72,537,225...72,938,349
Ensembl chr 8:72,537,225...72,938,349
|
|
G |
KCNV1 |
potassium voltage-gated channel modifier subfamily V member 1 |
multiple interactions |
EXP |
[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of KCNV1 mRNA |
CTD |
PMID:23626723 |
|
NCBI chr 8:109,963,636...109,975,771
Ensembl chr 8:109,963,636...109,975,771
|
|
G |
KLK6 |
kallikrein related peptidase 6 |
multiple interactions |
EXP |
[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of KLK6 mRNA |
CTD |
PMID:23626723 |
|
NCBI chr19:50,958,631...50,969,591
Ensembl chr19:50,958,631...50,969,673
|
|
G |
LAMP3 |
lysosomal associated membrane protein 3 |
decreases expression |
EXP |
4-nonylphenol results in decreased expression of LAMP3 mRNA |
CTD |
PMID:20678512 |
|
NCBI chr 3:183,122,215...183,163,813
Ensembl chr 3:183,122,215...183,163,839
|
|
G |
LEP |
leptin |
increases expression |
ISO |
4-nonylphenol results in increased expression of LEP protein |
CTD |
PMID:24388992 |
|
NCBI chr 7:128,241,278...128,257,629
Ensembl chr 7:128,241,278...128,257,629
|
|
G |
LHB |
luteinizing hormone subunit beta |
multiple interactions affects expression decreases expression increases secretion |
ISO |
4-nonylphenol inhibits the reaction [bisphenol A results in increased secretion of LHB protein]; 4-nonylphenol results in decreased expression of and results in decreased secretion of LHB protein; bisphenol A inhibits the reaction [4-nonylphenol results in increased secretion of LHB protein] 4-nonylphenol affects the expression of LHB protein 4-nonylphenol results in decreased expression of LHB protein |
CTD |
PMID:15888928 PMID:17033158 PMID:27087316 PMID:27109770 PMID:30228064 |
|
NCBI chr19:49,015,980...49,019,498
Ensembl chr19:49,015,980...49,017,091
|
|
G |
LPAR3 |
lysophosphatidic acid receptor 3 |
increases expression |
ISO |
4-nonylphenol results in increased expression of LPAR3 mRNA |
CTD |
PMID:24460192 |
|
NCBI chr 1:84,811,602...84,893,206
Ensembl chr 1:84,811,602...84,893,206
|
|
G |
LPL |
lipoprotein lipase |
increases expression |
ISO |
4-nonylphenol results in increased expression of LPL mRNA |
CTD |
PMID:24388992 |
|
NCBI chr 8:19,939,253...19,967,259
Ensembl chr 8:19,901,717...19,967,259
|
|
G |
LTF |
lactotransferrin |
multiple interactions |
EXP |
[4-nonylphenol co-treated with ESR1 protein] results in increased expression of LTF mRNA; [4-nonylphenol co-treated with ESR2 protein] results in increased expression of LTF mRNA |
CTD |
PMID:21783566 |
|
NCBI chr 3:46,435,645...46,485,234
Ensembl chr 3:46,435,645...46,485,234
|
|
G |
MAP1LC3A |
microtubule associated protein 1 light chain 3 alpha |
increases expression |
ISO |
4-nonylphenol results in increased expression of MAP1LC3A mRNA |
CTD |
PMID:30228064 |
|
NCBI chr20:34,546,844...34,560,345
Ensembl chr20:34,546,854...34,560,345
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
increases phosphorylation multiple interactions |
ISO |
4-nonylphenol results in increased phosphorylation of MAPK1 protein 4-nonylphenol inhibits the reaction [Estradiol results in increased phosphorylation of MAPK1 protein]; 4-nonylphenol inhibits the reaction [Estriol results in increased phosphorylation of MAPK1 protein]; 4-nonylphenol inhibits the reaction [Estrone results in increased phosphorylation of MAPK1 protein]; fulvestrant inhibits the reaction [4-nonylphenol results in increased phosphorylation of MAPK1 protein] 4-nonylphenol analog affects the reaction [Estradiol affects the phosphorylation of MAPK1 protein]; 4-nonylphenol analog affects the reaction [Estriol affects the phosphorylation of MAPK1 protein]; 4-nonylphenol analog affects the reaction [Estrone affects the phosphorylation of MAPK1 protein] |
CTD |
PMID:17174995 PMID:19463694 PMID:20870566 PMID:20950447 PMID:28849599 |
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
increases phosphorylation multiple interactions |
ISO |
4-nonylphenol results in increased phosphorylation of MAPK3 protein 4-nonylphenol inhibits the reaction [Estradiol results in increased phosphorylation of MAPK3 protein]; 4-nonylphenol inhibits the reaction [Estriol results in increased phosphorylation of MAPK3 protein]; 4-nonylphenol inhibits the reaction [Estrone results in increased phosphorylation of MAPK3 protein]; fulvestrant inhibits the reaction [4-nonylphenol results in increased phosphorylation of MAPK3 protein] 4-nonylphenol analog affects the reaction [Estradiol affects the phosphorylation of MAPK3 protein]; 4-nonylphenol analog affects the reaction [Estriol affects the phosphorylation of MAPK3 protein]; 4-nonylphenol analog affects the reaction [Estrone affects the phosphorylation of MAPK3 protein] |
CTD |
PMID:19463694 PMID:20870566 PMID:20950447 PMID:28849599 |
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
G |
MAPK8 |
mitogen-activated protein kinase 8 |
increases phosphorylation |
ISO |
4-nonylphenol analog results in increased phosphorylation of MAPK8 protein |
CTD |
PMID:27086933 |
|
NCBI chr10:48,306,677...48,439,360
Ensembl chr10:48,306,639...48,439,360
|
|
G |
MAPK9 |
mitogen-activated protein kinase 9 |
increases phosphorylation |
ISO |
4-nonylphenol analog results in increased phosphorylation of MAPK9 protein |
CTD |
PMID:27086933 |
|
NCBI chr 5:180,233,143...180,292,083
Ensembl chr 5:180,233,143...180,292,099
|
|
G |
MCL1 |
MCL1 apoptosis regulator, BCL2 family member |
decreases expression |
ISO |
4-nonylphenol results in decreased expression of MCL1 protein |
CTD |
PMID:26804764 |
|
NCBI chr 1:150,574,558...150,579,610
Ensembl chr 1:150,560,895...150,579,738
|
|
G |
MTOR |
mechanistic target of rapamycin kinase |
decreases phosphorylation multiple interactions increases phosphorylation |
ISO |
4-nonylphenol results in decreased phosphorylation of MTOR protein 4-nonylphenol inhibits the reaction [bisphenol A results in decreased expression of MTOR mRNA]; 4-nonylphenol inhibits the reaction [bisphenol A results in increased phosphorylation of MTOR protein]; Acetylcysteine inhibits the reaction [4-nonylphenol results in decreased phosphorylation of MTOR protein]; AICA ribonucleotide promotes the reaction [4-nonylphenol results in decreased phosphorylation of MTOR protein]; bisphenol A inhibits the reaction [4-nonylphenol results in increased phosphorylation of MTOR protein]; dorsomorphin inhibits the reaction [4-nonylphenol results in decreased phosphorylation of MTOR protein]; PRKAA1 protein promotes the reaction [4-nonylphenol results in decreased phosphorylation of MTOR protein] |
CTD |
PMID:26804764 PMID:28041982 PMID:30228064 |
|
NCBI chr 1:11,106,535...11,262,551
Ensembl chr 1:11,106,535...11,262,556
|
|
G |
NAALAD2 |
N-acetylated alpha-linked acidic dipeptidase 2 |
multiple interactions |
EXP |
[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of NAALAD2 mRNA |
CTD |
PMID:23626723 |
|
NCBI chr11:90,131,699...90,192,894
Ensembl chr11:90,131,515...90,192,894
|
|
G |
NID1 |
nidogen 1 |
multiple interactions |
EXP |
[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of NID1 mRNA |
CTD |
PMID:23626723 |
|
NCBI chr 1:235,975,830...236,065,090
Ensembl chr 1:235,975,830...236,065,109
|
|
G |
NR1I2 |
nuclear receptor subfamily 1 group I member 2 |
affects binding multiple interactions increases activity |
EXP ISO |
4-nonylphenol binds to NR1I2 protein 4-nonylphenol binds to and results in increased activity of NR1I2 protein 4-nonylphenol results in increased activity of NR1I2 protein 4-nonylphenol promotes the reaction [NR1I2 protein results in increased expression of CYP3A23-3A1 mRNA] |
CTD |
PMID:15792627 PMID:17483497 PMID:20869355 PMID:25680588 |
|
NCBI chr 3:119,782,101...119,818,487
Ensembl chr 3:119,780,484...119,818,487
|
|
G |
NR1I3 |
nuclear receptor subfamily 1 group I member 3 |
increases activity multiple interactions affects localization increases response to substance |
EXP ISO |
4-nonylphenol results in increased activity of NR1I3 protein; 4-nonylphenol results in increased activity of NR1I3 protein alternative form 1,5-benzothiazepine analog inhibits the reaction [4-nonylphenol results in increased activity of NR1I3 protein]; 4-nonylphenol binds to and results in increased activity of NR1I3 protein; 4-nonylphenol binds to and results in increased activity of NR1I3 protein alternative form; 4-nonylphenol inhibits the reaction [PK 11195 results in decreased activity of NR1I3 protein]; 4-nonylphenol promotes the reaction [NR1I3 protein results in increased expression of CYP2B10 mRNA]; 7-acetoxy-6,7-dihydro-6-(4-methoxyphenyl)pyrrolo(2,1-d)(1,5)benzothiazepine inhibits the reaction [4-nonylphenol results in increased activity of NR1I3 protein]; Clotrimazole inhibits the reaction [4-nonylphenol results in increased activity of NR1I3 protein]; PK 11195 results in decreased susceptibility to [4-nonylphenol binds to and results in increased activity of NR1I3 protein alternative form] 4-nonylphenol affects the localization of NR1I3 protein 4-nonylphenol inhibits the reaction [androstan-3-ol binds to and results in decreased activity of NR1I3 protein]; 4-nonylphenol promotes the reaction [NR1I3 protein results in increased expression of CYP2B6 mRNA]; [4-nonylphenol inhibits the reaction [androstan-3-ol binds to and results in decreased activity of NR1I3 protein]] which results in increased expression of CYP2B6 mRNA; NR1I3 protein promotes the reaction [4-nonylphenol results in increased expression of CYP2B10 mRNA] NR1I3 protein results in increased susceptibility to 4-nonylphenol |
CTD |
PMID:17483497 PMID:20869355 PMID:21227907 PMID:21315811 PMID:28927721 |
|
NCBI chr 1:161,229,669...161,238,203
Ensembl chr 1:161,229,666...161,238,244
|
|
G |
OR10H1 |
olfactory receptor family 10 subfamily H member 1 |
multiple interactions |
EXP |
[4-tert-octylphenol co-treated with 4-nonylphenol] results in increased expression of OR10H1 mRNA |
CTD |
PMID:23626723 |
|
NCBI chr19:15,804,549...15,815,664
Ensembl chr19:15,804,549...15,815,664
|
|
G |
OR2T10 |
olfactory receptor family 2 subfamily T member 10 |
multiple interactions |
EXP |
[4-tert-octylphenol co-treated with 4-nonylphenol] results in increased expression of OR2T10 mRNA |
CTD |
PMID:23626723 |
|
NCBI chr 1:248,590,487...248,597,700
Ensembl chr 1:248,590,487...248,597,700
|
|
G |
P4HB |
prolyl 4-hydroxylase subunit beta |
multiple interactions decreases activity |
ISO |
4-nonylphenol inhibits the reaction [Triiodothyronine, Reverse binds to P4HB protein] 4-nonylphenol results in decreased activity of P4HB protein |
CTD |
PMID:16617682 |
|
NCBI chr17:81,843,166...81,860,535
Ensembl chr17:81,843,159...81,860,856
|
|
G |
PCNA |
proliferating cell nuclear antigen |
increases expression decreases expression affects expression |
EXP ISO |
4-nonylphenol results in increased expression of PCNA mRNA 4-nonylphenol results in increased expression of PCNA protein 4-nonylphenol results in decreased expression of PCNA mRNA; 4-nonylphenol results in decreased expression of PCNA protein 4-nonylphenol affects the expression of PCNA mRNA |
CTD |
PMID:15461258 PMID:18839522 PMID:27087316 PMID:27109770 |
|
NCBI chr20:5,114,953...5,126,622
Ensembl chr20:5,114,953...5,126,626
|
|
G |
PDZK1 |
PDZ domain containing 1 |
increases expression |
EXP |
4-nonylphenol results in increased expression of PDZK1 mRNA |
CTD |
PMID:14605097 PMID:16393665 |
|
NCBI chr 1:145,670,852...145,707,400
Ensembl chr 1:145,670,852...145,708,148
|
|
G |
PGR |
progesterone receptor |
increases expression decreases expression |
EXP ISO |
4-nonylphenol results in increased expression of PGR mRNA 4-nonylphenol analog results in decreased expression of PGR mRNA |
CTD |
PMID:16393665 PMID:17033158 PMID:27086933 |
|
NCBI chr11:101,029,624...101,129,813
Ensembl chr11:101,029,624...101,129,813
|
|
G |
PIK3CG |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma |
multiple interactions increases expression |
ISO |
4-nonylphenol promotes the reaction [bisphenol A results in increased expression of PIK3CG mRNA]; bisphenol A promotes the reaction [4-nonylphenol results in increased expression of PIK3CG mRNA] |
CTD |
PMID:30228064 |
|
NCBI chr 7:106,865,282...106,908,980
Ensembl chr 7:106,865,278...106,908,980
|
|
G |
POU5F1 |
POU class 5 homeobox 1 |
increases expression |
ISO |
4-nonylphenol results in increased expression of POU5F1 mRNA |
CTD |
PMID:20615461 |
|
NCBI chr 6:31,164,337...31,170,682
Ensembl chr 6:31,164,337...31,180,731
|
|
G |
PPARG |
peroxisome proliferator activated receptor gamma |
increases expression |
ISO |
4-nonylphenol results in increased expression of PPARG mRNA |
CTD |
PMID:24388992 |
|
NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356
|
|
G |
PPFIA4 |
PTPRF interacting protein alpha 4 |
multiple interactions |
EXP |
[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of PPFIA4 mRNA |
CTD |
PMID:23626723 |
|
NCBI chr 1:203,026,491...203,078,736
Ensembl chr 1:203,026,491...203,078,740
|
|
G |
PRKAA1 |
protein kinase AMP-activated catalytic subunit alpha 1 |
multiple interactions |
ISO |
PRKAA1 protein promotes the reaction [4-nonylphenol results in decreased phosphorylation of EIF4EBP1 protein]; PRKAA1 protein promotes the reaction [4-nonylphenol results in decreased phosphorylation of MTOR protein]; PRKAA1 protein promotes the reaction [4-nonylphenol results in decreased phosphorylation of RPS6KB1 protein]; PRKAA1 protein promotes the reaction [4-nonylphenol results in increased expression of BECN1 protein] |
CTD |
PMID:28041982 |
|
NCBI chr 5:40,759,389...40,798,374
Ensembl chr 5:40,759,389...40,798,374
|
|
G |
PRKAA2 |
protein kinase AMP-activated catalytic subunit alpha 2 |
multiple interactions |
ISO |
[4-nonylphenol results in increased susceptibility to bisphenol A] which results in decreased expression of PRKAA2 mRNA; [bisphenol A co-treated with 4-nonylphenol] results in decreased expression of PRKAA2 mRNA |
CTD |
PMID:30228064 |
|
NCBI chr 1:56,645,314...56,715,335
Ensembl chr 1:56,645,314...56,715,335
|
|
G |
PRL |
prolactin |
increases expression multiple interactions increases secretion |
ISO |
4-nonylphenol results in increased expression of PRL mRNA fulvestrant inhibits the reaction [4-nonylphenol results in increased expression of PRL mRNA]; fulvestrant inhibits the reaction [4-nonylphenol results in increased secretion of PRL protein] 4-nonylphenol affects the reaction [Estriol results in increased secretion of PRL protein]; 4-nonylphenol inhibits the reaction [Estradiol results in increased secretion of PRL protein]; 4-nonylphenol inhibits the reaction [Estrone results in increased secretion of PRL protein] |
CTD |
PMID:17174995 PMID:19463694 PMID:20950447 |
|
NCBI chr 6:22,287,246...22,302,835
Ensembl chr 6:22,287,244...22,302,826
|
|
G |
PTEN |
phosphatase and tensin homolog |
increases expression multiple interactions decreases phosphorylation |
ISO |
4-nonylphenol results in increased expression of PTEN mRNA 4-nonylphenol promotes the reaction [bisphenol A results in decreased phosphorylation of PTEN protein]; bisphenol A inhibits the reaction [4-nonylphenol results in decreased phosphorylation of PTEN protein] |
CTD |
PMID:30228064 |
|
NCBI chr10:87,863,625...87,971,930
Ensembl chr10:87,862,638...87,971,930
|
|
G |
RHBDF2 |
rhomboid 5 homolog 2 |
affects response to substance multiple interactions |
ISO |
RHBDF2 protein affects the susceptibility to 4-nonylphenol [RHBDF2 protein affects the susceptibility to 4-nonylphenol] which affects the secretion of BTC protein |
CTD |
PMID:28703301 |
|
NCBI chr17:76,470,893...76,501,427
Ensembl chr17:76,470,891...76,501,790
|
|
G |
ROPN1B |
rhophilin associated tail protein 1B |
multiple interactions |
EXP |
[4-tert-octylphenol co-treated with 4-nonylphenol] results in increased expression of ROPN1B mRNA |
CTD |
PMID:23626723 |
|
NCBI chr 3:125,969,178...125,983,454
Ensembl chr 3:125,969,160...125,983,454
|
|
G |
RPS6KB1 |
ribosomal protein S6 kinase B1 |
multiple interactions decreases phosphorylation |
ISO |
Acetylcysteine inhibits the reaction [4-nonylphenol results in decreased phosphorylation of RPS6KB1 protein]; dorsomorphin inhibits the reaction [4-nonylphenol results in decreased phosphorylation of RPS6KB1 protein]; PRKAA1 protein promotes the reaction [4-nonylphenol results in decreased phosphorylation of RPS6KB1 protein] |
CTD |
PMID:26804764 PMID:28041982 |
|
NCBI chr17:59,893,121...59,950,574
Ensembl chr17:59,893,046...59,950,574
|
|
G |
RXRA |
retinoid X receptor alpha |
decreases expression |
ISO |
4-nonylphenol results in decreased expression of RXRA mRNA |
CTD |
PMID:16013040 |
|
NCBI chr 9:134,326,455...134,440,585
Ensembl chr 9:134,317,098...134,440,585
|
|
G |
S100G |
S100 calcium binding protein G |
increases expression |
ISO |
4-nonylphenol results in increased expression of S100G mRNA; 4-nonylphenol results in increased expression of S100G protein |
CTD |
PMID:17365578 |
|
NCBI chr X:16,650,158...16,654,670
Ensembl chr X:16,650,158...16,654,670
|
|
G |
SBSPON |
somatomedin B and thrombospondin type 1 domain containing |
multiple interactions |
EXP |
[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of SBSPON mRNA |
CTD |
PMID:23626723 |
|
NCBI chr 8:73,064,543...73,093,172
Ensembl chr 8:73,064,543...73,124,088
|
|
G |
SDR16C5 |
short chain dehydrogenase/reductase family 16C member 5 |
multiple interactions |
EXP |
[4-tert-octylphenol co-treated with 4-nonylphenol] results in increased expression of SDR16C5 mRNA |
CTD |
PMID:23626723 |
|
NCBI chr 8:56,300,005...56,320,175
Ensembl chr 8:56,300,005...56,320,776
|
|
G |
SERF1A |
small EDRK-rich factor 1A |
multiple interactions |
EXP |
[4-tert-octylphenol co-treated with 4-nonylphenol] results in increased expression of SERF1A mRNA |
CTD |
PMID:23626723 |
|
NCBI chr 5:70,900,669...70,918,530
Ensembl chr 5:70,025,251...70,043,113 Ensembl chr 5:70,025,251...70,043,113
|
|
G |
SHBG |
sex hormone binding globulin |
affects binding |
EXP |
4-nonylphenol binds to SHBG protein |
CTD |
PMID:25349334 |
|
NCBI chr17:7,614,064...7,633,372
Ensembl chr17:7,613,946...7,633,382
|
|
G |
SKIL |
SKI like proto-oncogene |
increases expression |
EXP |
4-nonylphenol results in increased expression of SKIL protein |
CTD |
PMID:24308608 |
|
NCBI chr 3:170,357,715...170,396,849
Ensembl chr 3:170,357,342...170,396,835
|
|
G |
SLC7A7 |
solute carrier family 7 member 7 |
multiple interactions |
EXP |
[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of SLC7A7 mRNA |
CTD |
PMID:23626723 |
|
NCBI chr14:22,773,222...22,819,791
Ensembl chr14:22,773,222...22,829,820
|
|
G |
SMAD3 |
SMAD family member 3 |
multiple interactions decreases phosphorylation |
EXP |
fulvestrant inhibits the reaction [4-nonylphenol results in decreased phosphorylation of SMAD3 protein] |
CTD |
PMID:24308608 |
|
NCBI chr15:67,065,602...67,195,169
Ensembl chr15:67,063,763...67,195,173
|
|
G |
SOD1 |
superoxide dismutase 1 |
decreases expression |
ISO |
4-nonylphenol results in decreased expression of SOD1 mRNA |
CTD |
PMID:27087316 PMID:27109770 |
|
NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931
|
|
G |
SP1 |
Sp1 transcription factor |
multiple interactions |
ISO |
[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in decreased expression of SP1 mRNA |
CTD |
PMID:29029336 |
|
NCBI chr12:53,380,176...53,416,446
Ensembl chr12:53,380,176...53,416,446
|
|
G |
SREBF1 |
sterol regulatory element binding transcription factor 1 |
increases expression |
ISO |
4-nonylphenol results in increased expression of SREBF1 mRNA |
CTD |
PMID:24388992 |
|
NCBI chr17:17,811,334...17,836,986
Ensembl chr17:17,810,399...17,837,002
|
|
G |
STAR |
steroidogenic acute regulatory protein |
multiple interactions |
ISO |
[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of STAR mRNA |
CTD |
PMID:29029336 |
|
NCBI chr 8:38,142,700...38,150,952
Ensembl chr 8:38,142,700...38,150,992
|
|
G |
SULT1A1 |
sulfotransferase family 1A member 1 |
increases metabolic processing |
EXP |
SULT1A1 protein results in increased metabolism of 4-nonylphenol |
CTD |
PMID:10623578 |
|
NCBI chr16:28,605,258...28,623,375
Ensembl chr16:28,605,196...28,610,044
|
|
G |
SULT1A3 |
sulfotransferase family 1A member 3 |
increases metabolic processing |
EXP |
SULT1A3 protein results in increased metabolism of 4-nonylphenol |
CTD |
PMID:10623578 |
|
NCBI chr16:30,199,255...30,204,310
Ensembl chr16:30,199,228...30,204,310
|
|
G |
SULT1B1 |
sulfotransferase family 1B member 1 |
increases metabolic processing |
EXP |
SULT1B1 protein results in increased metabolism of 4-nonylphenol |
CTD |
PMID:10623578 |
|
NCBI chr 4:69,721,167...69,760,620
Ensembl chr 4:69,721,167...69,787,961
|
|
G |
SULT1E1 |
sulfotransferase family 1E member 1 |
multiple interactions |
EXP |
4-nonylphenol inhibits the reaction [Progesterone results in increased expression of SULT1E1 mRNA] |
CTD |
PMID:22414680 |
|
NCBI chr 4:69,821,122...69,860,145
Ensembl chr 4:69,841,212...69,860,145
|
|
G |
SULT2A1 |
sulfotransferase family 2A member 1 |
increases metabolic processing |
EXP |
SULT2A1 protein results in increased metabolism of 4-nonylphenol |
CTD |
PMID:10623578 |
|
NCBI chr19:47,870,467...47,886,315
Ensembl chr19:47,870,467...47,886,315
|
|
G |
TF |
transferrin |
increases expression |
ISO |
4-nonylphenol analog results in increased expression of TRF mRNA |
CTD |
PMID:27086933 |
|
NCBI chr 3:133,661,998...133,796,641
Ensembl chr 3:133,746,040...133,796,641
|
|
G |
TFF1 |
trefoil factor 1 |
increases expression |
EXP |
4-nonylphenol results in increased expression of TFF1 mRNA |
CTD |
PMID:16393665 |
|
NCBI chr21:42,362,282...42,366,535
Ensembl chr21:42,362,282...42,366,535
|
|
G |
TGFA |
transforming growth factor alpha |
multiple interactions increases secretion |
ISO |
ADAM10 protein affects the reaction [ADAM17 protein affects the reaction [4-nonylphenol results in increased secretion of TGFA protein]]; ADAM17 protein affects the reaction [4-nonylphenol results in increased secretion of TGFA protein]; GW280264X inhibits the reaction [4-nonylphenol results in increased secretion of TGFA protein] |
CTD |
PMID:28703301 |
|
NCBI chr 2:70,447,284...70,553,826
Ensembl chr 2:70,447,284...70,554,193
|
|
G |
THRB |
thyroid hormone receptor beta |
multiple interactions |
EXP |
4-nonylphenol inhibits the reaction [Triiodothyronine results in increased activity of THRB protein] |
CTD |
PMID:31077750 |
|
NCBI chr 3:24,117,153...24,495,708
Ensembl chr 3:24,117,153...24,495,756
|
|
G |
TNF |
tumor necrosis factor |
affects secretion increases expression decreases expression |
EXP ISO |
4-nonylphenol affects the secretion of TNF protein 4-nonylphenol results in increased expression of TNF mRNA; 4-nonylphenol results in increased expression of TNF protein 4-nonylphenol results in decreased expression of TNF protein |
CTD |
PMID:20194071 PMID:27109770 PMID:28490175 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
TP53 |
tumor protein p53 |
increases expression increases phosphorylation |
ISO EXP |
4-nonylphenol results in increased expression of TP53 mRNA; 4-nonylphenol results in increased expression of TP53 protein 4-nonylphenol results in increased phosphorylation of TP53 protein |
CTD |
PMID:27087316 PMID:27109770 PMID:32466334 |
|
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,546
|
|
G |
TRMT9B |
tRNA methyltransferase 9B (putative) |
multiple interactions |
EXP |
[4-tert-octylphenol co-treated with 4-nonylphenol] results in increased expression of TRMT9B mRNA |
CTD |
PMID:23626723 |
|
NCBI chr 8:12,945,673...13,029,777
Ensembl chr 8:12,945,642...13,031,503
|
|
G |
TSC2 |
TSC complex subunit 2 |
decreases phosphorylation multiple interactions |
ISO |
4-nonylphenol results in decreased phosphorylation of TSC2 protein dorsomorphin inhibits the reaction [4-nonylphenol results in decreased phosphorylation of TSC2 protein] |
CTD |
PMID:26804764 PMID:28041982 |
|
NCBI chr16:2,047,985...2,089,491
Ensembl chr16:2,047,967...2,089,491
|
|
G |
TTR |
transthyretin |
multiple interactions |
EXP |
4-nonylphenol inhibits the reaction [Thyroxine binds to TTR protein] |
CTD |
PMID:31077750 |
|
NCBI chr18:31,591,877...31,598,821
Ensembl chr18:31,557,009...31,598,833
|
|
G |
VIPR1 |
vasoactive intestinal peptide receptor 1 |
multiple interactions |
EXP |
[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of VIPR1 mRNA |
CTD |
PMID:23626723 |
|
NCBI chr 3:42,489,299...42,537,568
Ensembl chr 3:42,489,299...42,537,573
|
|